|
OCLN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.591800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.838400E-03 |
| Normal-vs-Stage2 |
2.323000E-03 |
| Normal-vs-Stage3 |
2.019100E-04 |
| Normal-vs-Stage4 |
7.55540000000332E-05 |
| Stage1-vs-Stage2 |
2.355600E-01 |
| Stage1-vs-Stage3 |
7.538400E-02 |
| Stage1-vs-Stage4 |
3.609900E-02 |
| Stage2-vs-Stage3 |
8.655600E-01 |
| Stage2-vs-Stage4 |
5.984200E-01 |
| Stage3-vs-Stage4 |
6.779800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.211600E-04 |
| Normal-vs-AfricanAmerican |
5.385200E-01 |
| Normal-vs-Asian |
4.861900E-03 |
| Caucasian-vs-AfricanAmerican |
1.760160E-01 |
| Caucasian-vs-Asian |
7.020400E-01 |
| AfricanAmerican-vs-Asian |
1.117400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.975970E-02 |
| Normal-vs-Female |
2.763900E-04 |
| Male-vs-Female |
4.775400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.216840E-01 |
| Normal-vs-Age(41-60Yrs) |
3.767700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.63739999999857E-05 |
| Normal-vs-Age(81-100Yrs) |
1.411660E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.629600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.263100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.884200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.995200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.523200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.129600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.583900E-03 |
| Classical-VS-Follicular |
6.471000E-01 |
| Classical-VS-Other |
2.303800E-01 |
| Classical-VS-Normal |
5.715700E-03 |
| Tall-VS-Follicular |
6.241900E-02 |
| Tall-VS-Other |
6.941200E-01 |
| Tall-VS-Normal |
3.61910000000742E-05 |
| Follicular-VS-Other |
1.201410E-01 |
| Follicular-VS-Normal |
1.210110E-02 |
| Other-VS-Normal |
7.498000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.477400E-03 |
| Normal-vs-N1 |
3.752200E-04 |
| N0-vs-N1 |
2.099800E-01 |
|
|
